Press-release for stocks related to phase 2

Prices are updated after-hours

Crinetics Reviews CRN04777 Phase 1 Single-ascending Dose Results
Published: 2021-09-15 (Crawled : 20:00) - crinetics.com
CRNX G | $44.21 1.77% 1.74% 610K

| 84.85% | O: -0.47% H: 2.91% C: 0.64%
phase 1 results phase 3 phase 2

| 146.82% | O: 10.0% H: 6.56% C: -1.24%
phase 1 phase 2 phase 3

78%

22%

MTTR | News 4 | $4.6 164.37% 62.17% 28M

AGBA | $2.94 135.2% 57.48% 66M

EDBL | News | $6.46 71.81% 41.8% 2M

MTC | $2.25 44.23% 30.67% 6M

OPRT | News | $3.175 41.11% 29.13% 12M

SHIM | $3.05 35.56% 26.23% 1.1M

HKIT | $1.345 31.86% 24.16% 390K

ABVC | $1.36 30.77% 23.53% 7.4M

OST | $0.512 28.0% 21.88% 290K

POET | $1.59 27.2% 21.38% 4.2M

Save your searches and get alerts when important news are released.